EZP-22878-70844
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 191 / PA
- Registered
- 2022-06-30
- Relationship
- Child or adolescent in my care
- Guardian
- R8Q-23136-42683
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-24
Dose 1 — Pfizer-BioNTech
-
2022-06-30
Registered in v-safe
-
2022-06-30
Survey response — days 1–6 daily, dose 1, dependentMedDRA: COVID-19 — Feeling: Poor · Fever · Chills, Headache, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Positive for COVID on 6/29MedDRA releases: 2024-11 · check-in free text available
-
2022-07-01
Health check-in — day 7, dose 1, dependentFeeling: Poor · Fever · Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-07-08
-
2022-07-16
Dose 2 — Pfizer-BioNTech
- 2022-07-16
- 2022-07-23
- 2022-07-30
- 2022-08-08
- 2022-08-18
- 2022-08-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-24 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
Free text
Release 12 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Positive for COVID on 6/29
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release